Eric Dinkel

Eric Dinkel is an accomplished finance professional with extensive experience in financial planning and analysis across major organizations within the healthcare and pharmaceutical sectors. Currently serving as the Director of Finance Planning & Analysis for Phibro Animal Health, Eric leads initiatives in financial reporting and business analysis to support decision-making processes in North America. Prior roles include key financial positions at Amgen, Pfizer, Hospira, Cardinal Health, and Baxter International Inc., where Eric managed global budgets, established financial leadership in research and development, and drove strategic financial initiatives across various business units. Eric holds a Bachelor of Accountancy from New Mexico State University and an Executive MBA from The University of New Mexico.